InflaRx (IFRX) Net Income (2016 - 2026)
InflaRx's (IFRX) quarterly Net Income came in at -$12.4 million in Q2 2026, up 24.15% year-over-year from -$10.0 million in Q2 2025, and down 89.04% quarter-over-quarter from -$6.5 million in Q1 2026.
Analysis
InflaRx (IFRX) Net Income (2016 - 2026) Analysis & Trends
InflaRx has disclosed Net Income across 11 years of filings, most recently posting -$12.4 million for Q2 2026.
- In Q2 2026, Net Income rose 24.15% year-over-year to -$12.4 million; the TTM figure through Jun 2026 stood at $60.6 million (up 2215.33% YoY), while the FY2025 annual figure was $51.6 million, up 4.74% from the prior year.
- Net Income came in at -$12.4 million for Q2 2026 at InflaRx, down from -$6.5 million in the prior quarter.
- In the past five years, Net Income ranged from a high of $93.9 million in Q4 2025 to a low of -$70.8 million in Q3 2024.
- Average Net Income over 5 years is $8.8 million, with a median of -$9.6 million recorded in 2024.
- Year-over-year, Net Income surged 458.62% in 2022 and slumped 145.7% in 2025.
- Over 5 years, Net Income stood at $52.0 million in 2022, then jumped by 43.68% to $74.7 million in 2023, then gained by 24.52% to $93.0 million in 2024, then rose by 0.93% to $93.9 million in 2025, then tumbled by 113.19% to -$12.4 million in 2026.
- Per Business Quant data, the three most recent Net Income figures were -$12.4 million in Q2 2026, -$6.5 million in Q1 2026, and $93.9 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 2.38 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -10.50 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 1.10 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 1.30 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 601.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -782.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 164.49 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 97.50 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -290.61 Mn |
| 10 | InflaRx | 139.29 Mn | -44.96 Mn | 2.74 Mn | -12.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12.38 Mn |
| Mar 31, 2026 | -6.55 Mn |
| Dec 31, 2025 | 93.85 Mn |
| Sep 30, 2025 | -14.33 Mn |
| Jun 30, 2025 | -16.32 Mn |
| Mar 31, 2025 | -8.75 Mn |
| Dec 31, 2024 | 92.99 Mn |
| Sep 30, 2024 | -70.79 Mn |
| Jun 30, 2024 | 35.71 Mn |
| Mar 31, 2024 | -10.49 Mn |
| Dec 31, 2023 | 74.68 Mn |
| Sep 30, 2023 | -50.10 Mn |
| Jun 30, 2023 | 33.07 Mn |
| Mar 31, 2023 | -11.90 Mn |
| Dec 31, 2022 | 51.97 Mn |
| Sep 30, 2022 | -35.28 Mn |
| Jun 30, 2022 | 29.39 Mn |
| Mar 31, 2022 | -15.72 Mn |
| Dec 31, 2021 | -14.49 Mn |
| Sep 30, 2021 | -63.53 Mn |